Fairmount Funds Management LLC: DAMORA THERAPEUTICS INC (DMRA): Quarterly 13F Position History
As of Q2 2026, Fairmount Funds Management LLC reported 8,713,000 shares of DAMORA THERAPEUTICS INC (DMRA), worth $226.6M and representing 15.0% of its 13F equity book. The position first appeared in Q1 2026 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 8,713,000Shares Held (Latest Filing)
- $226.6MReported Market Value (Latest Filing)
- 15.0%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- +$958.4KQuarter-over-Quarter Value Change
- 8,713,000Peak Reported Shares (Historical)
Recent initiation: Fairmount Funds Management LLC first reported DMRA on the Q1 2026 filing, so fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 8,713,000 | 0 | – | $226.6M | 15.0% | $26.0 |
| Q1 2026 | 8,713,000 | – | – | $225.7M | 16.3% | $25.9 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Fairmount Funds Management LLC first disclose a DMRA position in 13F-HR filings?
Fairmount Funds Management LLC first reported DAMORA THERAPEUTICS INC (DMRA) on its 13F-HR filing for the period ending 2026-03-31 (Q1 2026). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Fairmount Funds Management LLC's most recent quarter-over-quarter share-count change in DMRA?
Fairmount Funds Management LLC held the same 8,713,000 shares of DMRA between Q1 2026 and Q2 2026, so the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent Fairmount Funds Management LLC's cost basis in DMRA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.